| Autor: |
Alfieri V; Dept of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy veronica.alfieri@unipr.it.; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK., Crisafulli E; Dept of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy.; Dept of Medicine, Respiratory Medicine Unit, University of Verona, Verona, Italy., Visca D; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.; Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy., Chong WH; Dept of Radiology, Tuen Mun Hospital, Hong Kong SAR.; Dept of Radiology, Royal Brompton Hospital, London, UK., Stock C; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College, London, UK., Mori L; Respiratory Medicine, Northwick Park Hospital, Harrow, UK., de Lauretis A; Unità Operativa Complessa di Pneumologia, ASST-Rhodese, Garbagnate Milanese, Italy., Tsipouri V; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK., Chua F; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK., Kouranos V; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK., Kokosi M; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK., Hogben C; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK., Molyneaux PL; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College, London, UK., George PM; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College, London, UK., Maher TM; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College, London, UK., Chetta AA; Dept of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy., Sestini P; Dept of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy., Wells AU; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College, London, UK., Renzoni EA; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College, London, UK. |
| Abstrakt: |
Competing Interests: Conflict of interest: V. Alfieri has nothing to disclose. Conflict of interest: E. Crisafulli has nothing to disclose. Conflict of interest: D. Visca has nothing to disclose. Conflict of interest: W.H. Chong has nothing to disclose. Conflict of interest: C. Stock has nothing to disclose. Conflict of interest: L. Mori has nothing to disclose. Conflict of interest: A. de Lauretis has nothing to disclose. Conflict of interest: V. Tsipouri has nothing to disclose. Conflict of interest: F. Chua reports lecture fees and advisory board fees from Boehringer Ingelheim and from Roche, outside the submitted work. Conflict of interest: V. Kouranos has nothing to disclose. Conflict of interest: M. Kokosi has nothing to disclose. Conflict of interest: C. Hogben has nothing to disclose. Conflict of interest: P.L. Molyneaux has, via his institution, received industry-academic funding from Roche, Boehringer Ingelheim and Galapagos and has received speaker fees from Roche. Conflict of interest: P.M. George reports grants, personal fees and non-financial support from Boehringer Ingelheim, personal fees and non-financial support from Roche, personal fees from Teva, outside the submitted work. Conflict of interest: T.M. Maher has, via his institution, received industry-academic funding from GlaxoSmithKline R&D and UCB and has received consultancy or speaker fees from Apellis, AstraZeneca, Bayer, Blade Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Galapagos, GlaxoSmithKline R&D, Indalo, Novartis, Pliant, ProMetic, Respivnat, Roche, Samumed and UCB. Conflict of interest: A.A. Chetta has nothing to disclose. Conflict of interest: P. Sestini has nothing to disclose. Conflict of interest: A.U. Wells reports lecture fees and advisory board fees from Boeringher Ingelheim, Roche and Bayer, outside the submitted work. Conflict of interest: E.A. Renzoni reports lecture fees and advisory board fees from Boeringher Ingelheim and Roche, and lecture fees from Mundipharma, outside the submitted work. |
